Currently predicting for Thu, 4 Jun 2026

BLRX Prediction Chart

BLRX Predictions History

Latest community submissions for BLRX.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 27, 2024 $1.06 -97.43% $1.11 X 95.25% 1
Mar 27, 2024 Bullish $1.11 X 1
JS JS Pro
Mar 11, 2024 $1.17 -97.52% $1.14 V 97.37% 1
Mar 11, 2024 $1.22 -97.41% $1.14 X 92.77% 0
Mar 11, 2024 $1.21 -97.44% $1.14 X 94.17% 0
JS JS Pro
Oct 13, 2023 $1.57 -97.45% $1.60 X 98.13% 1
Oct 13, 2023 $1.47 -97.62% $1.60 V 91.65% 0
Oct 13, 2023 $1.49 -97.57% $1.60 V 93.38% 0
Sep 7, 2023 $2.35 -97.58% $2.17 V 91.93% 1
Sep 7, 2023 $2.37 -97.55% $2.17 V 90.64% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BLRX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIOLINERX LTD.
BioLineRx
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE